Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Leases (2022 - 2024)

RAPT Therapeutics' Leases history spans 3 years, with the latest figure at $3.8 million for Q3 2024.

  • For Q3 2024, Leases fell 32.56% year-over-year to $3.8 million; the TTM value through Sep 2024 reached $3.8 million, down 32.56%, while the annual FY2023 figure was $5.2 million, 24.67% down from the prior year.
  • Leases for Q3 2024 was $3.8 million at RAPT Therapeutics, down from $4.3 million in the prior quarter.
  • Across five years, Leases topped out at $6.9 million in Q4 2022 and bottomed at $3.8 million in Q3 2024.
  • The 3-year median for Leases is $5.8 million (2022), against an average of $5.6 million.
  • The largest annual shift saw Leases grew 3.23% in 2023 before it crashed 32.56% in 2024.
  • A 3-year view of Leases shows it stood at $6.9 million in 2022, then decreased by 24.67% to $5.2 million in 2023, then decreased by 26.84% to $3.8 million in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Leases are $3.8 million (Q3 2024), $4.3 million (Q2 2024), and $4.8 million (Q1 2024).